抗体-配体基序的设计优化以增强 CAR-T 抗实体瘤重定向活性 Design optimization of antibody-ligand motifs to enhance CAR-T redirection activity against solid tumors. PubMed 2026/06/25 发表Cell Rep MedQ1 · IF 14(JCR 2025) 靶点:HER2靶点:ROR1靶点:VEGFR技术:CAR-T实体瘤地区:中国
受体酪氨酸激酶样孤儿受体作为癌症免疫治疗的潜在靶点 Receptor tyrosine kinase-like orphan receptor serves as a potential target in cancer immunotherapy. PubMed 2025/02/13 发表J Leukoc BiolQ2 · IF 3.4(JCR 2025) 靶点:ROR1血液系统恶性肿瘤实体瘤地区:中国
临床前研究中开发靶向 ROR1 的 CAR-T 细胞抗实体瘤 Developing ROR1 Targeting CAR-T Cells against Solid Tumors in Preclinical Studies. PubMed 2022/07/25 发表Cancers (Basel)Q2 · IF 4.8(JCR 2025) 靶点:ROR1技术:CAR-TB 细胞恶性肿瘤实体瘤地区:中国